Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | HCAR3 | P49019 | 11/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30525281 | 0.90 | VCAM1 (0.64) | LMNAMAPTMEN1GAAHPGD | |
| SCHEMBL559830 | 0.90 | VCAM1 (0.64) | LMNAMAPTMEN1GAAHPGD | |
| Methane SCHEMBL27578247 | 0.89 | VCAM1 (0.62) | LMNAMAPTMEN1GAAHPGD | |
| SCHEMBL2116235 | 0.88 | VCAM1 (0.61) | CASP6TSHRHCAR3LMNAMAPT | |
| SCHEMBL2388784 | 0.88 | VCAM1 (0.54) | LMNAMAPTMEN1GAAHPGD | |
| SCHEMBL2722165 | 0.88 | CASP6 (0.60) | CASP6TSHRHCAR3LMNAMAPT | |
| SCHEMBL16960905 | 0.88 | VCAM1 (0.54) | TSHRHCAR3LMNAMAPTMEN1 | |
| SCHEMBL31548461 | 0.88 | CASP6 (0.60) | CASP6TSHRHCAR3LMNAMAPT | |
| SCHEMBL28230999 | 0.87 | MAPT (0.51) | CASP6TSHRHCAR3LMNAMAPT | |
| SCHEMBL11685716 | 0.86 | VCAM1 (0.52) | TSHRLMNAMAPTMEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122054815-A | Optical repair type perovskite photoelectric device and performance repair method thereof | 中核光电科技(上海)有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-111116494-B | Amide compounds containing quinazolinedione structure, preparation method and application thereof | 江苏中旗科技股份有限公司 | 2022-08-16 | — | — | CN | claimed |
| CN-111592465-A | Method for preparing 2-amino-4-aminomethyl methyl benzoate and hydrochloride thereof | 武汉珈汇精化科技有限公司 | 2020-08-28 | — | — | CN | claimed |
| CN-111116494-A | Amide compounds containing quinazolinedione structure, preparation method and application thereof | 江苏中旗科技股份有限公司 | 2020-05-08 | — | — | CN | claimed |
| CN-122054815-A | Optical repair type perovskite photoelectric device and performance repair method thereof | 中核光电科技(上海)有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-119118994-A | Selective glutaminyl cyclase isozyme inhibitor, and preparation method and application thereof | 深圳大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-118480009-A | Compositions and methods for modulating short-chain dehydrogenase activity | 卡斯西部储备大学 | 2024-08-13 | — | — | CN | disclosed |
| CN-116751187-B | Indolyl pyrimidine dual-targeting inhibitor, preparation method and application thereof | 西南交通大学 | 2024-03-19 | — | — | CN | disclosed |
| US-20240066136-A1 | MODIFIED PROTEINS AND PROTEIN DEGRADERS | CULLGEN (SHANGHAI), INC. (CN) | 2024-02-29 | — | — | US | disclosed |
| US-20240066136-A1 | MODIFIED PROTEINS AND PROTEIN DEGRADERS | CULLGEN (SHANGHAI), INC. (CN) | 2024-02-29 | — | — | US | disclosed |
| CN-116940562-A | Acetamido-phenylbenzamide derivatives and methods of use thereof | 希华医药有限公司 | 2023-10-24 | — | — | CN | disclosed |
| US-20230322684-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE | CASE WESTERN RESERVE UNIVERSITY | 2023-10-12 | — | — | US | disclosed |
| WO-1993000095-A2 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-01-07 | — | — | WO | disclosed |
| CN-1053063-A | Quinazoline derivant and preparation method thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1991-07-17 | — | — | CN | disclosed |
| EP-0436157-A1 | Quinazoline derivatives and their preparation | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-07-10 | — | — | EP | disclosed |
| EP-0320939-A2 | Silver halide color photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1989-06-21 | — | — | EP | disclosed |
| US-4505794-A | PHOTOINITIATORS WITH AMINES FOR PHOTOPOLYMERIZATION OF UNSATURATEDCOMPOUNDS; SOLUBILITY | CIBA-GEIGY CORPORATION (US) | 1985-03-19 | — | — | US | disclosed |
| US-4506083-A | INITIATORS FOR PHOTOPOLYMERIZATION OR PHOTOCHEMICAL CROSSLINKING | CIBA-GEIGY CORPORATION (US) | 1985-03-19 | — | — | US | disclosed |
| US-4056522-A | PIGMENTS | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-11-01 | — | — | US | disclosed |
| US-4056553-A | INTERMEDIATES FOR MONOAZO DYES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240066136-A1 | MODIFIED PROTEINS AND PROTEIN DEGRADERS | DDB1, DCLRE1A, MDM2 | CASP6 1980/4885TSHR 3370/4885HCAR3 4166/4885 |
| US-20230322684-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE | HPGD, GCDH, HPGDS | CASP6 3477/4885TSHR 3972/4885HCAR3 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.